Revenio's €290 Million Power Play: What the Visionix Acquisition Means for Eye Care

In a major strategic move, Finnish medical device company Revenio Group has acquired Visionix International for €290 million, marking a significant expansion in the ophthalmic technology space. White & Case guided the deal, helping Revenio strengthen its position as a leader in eye care innovation.